Welcome to our dedicated page for Invech Holdings SEC filings (Ticker: IVHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for Invech Holdings, Inc. (IVHI), a Nevada corporation with common stock quoted on the OTC Markets. Through these documents, investors can review how the company reports material events, trading status, and regulatory developments under the Securities Exchange Act of 1934.
In a recent Form 8-K, Invech Holdings, Inc. disclosed that FINRA deemed effective a Form 15c2-11 (Form 211) submitted by Glendale Securities, Inc. for the company’s common stock. The filing explains that this effectiveness allows Glendale Securities, Inc. to resume publishing quotes for IVHI in an over-the-counter quotation medium, which the company characterizes as a significant step for increasing visibility and liquidity in the public market.
On Stock Titan, IVHI filings such as Form 8-K are updated in near real time from EDGAR and are paired with AI-powered summaries that highlight the key points, such as changes in quotation eligibility, market-maker activity, and other “Other Events” reported under Section 8. These summaries are designed to make it easier to understand how specific filings may relate to trading in the company’s common stock.
Users can also review other core filing types for Invech Holdings, Inc., including annual and quarterly reports when available, as well as ownership and insider-transaction disclosures like Form 4. The goal is to provide a structured view of IVHI’s regulatory history, allowing investors to move from headline AI insights into the full text of each filing for deeper analysis.
Invech Holdings, Inc. reported that on September 8, 2025, FINRA deemed effective a Form 15c2-11 (Form 211) submitted by Glendale Securities, Inc. for the company’s common stock. This effectiveness permits Glendale Securities to resume publishing quotations for Invech’s shares on an over-the-counter quotation platform.
The company states that this step is important for increasing the visibility and liquidity of its common stock in public markets. Invech also notes that it is working with partners to strengthen its market presence and to provide more transparent and timely information to shareholders and the wider investment community.
Invech Holdings, Inc. reported that on September 8, 2025, FINRA deemed effective a Form 15c2-11 (Form 211) submitted by Glendale Securities, Inc. for the company’s common stock. This effectiveness permits Glendale Securities to resume publishing quotations for Invech’s shares on an over-the-counter quotation platform.
The company states that this step is important for increasing the visibility and liquidity of its common stock in public markets. Invech also notes that it is working with partners to strengthen its market presence and to provide more transparent and timely information to shareholders and the wider investment community.